RxDoctor Payments DataLook up a doctor →

Michael Bookman

Medical Oncology · Tucson, AZNPI 1972570836

Payments from drug & device makers

$4,774,068in general payments, 2019–2025

Across 431 payments — averaging $11,077 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2.7M
  • Tesaro, Inc.$984K
  • Genentech, Inc.$787K
  • GSK$124K
  • Eli Lilly$61K
  • AstraZeneca$43K
  • plus $40K from 10 others
$2,701in research payments, 2019–2025

Across 9 payments — averaging $300.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$3K
  • AbbVie$22

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,774,068 in reported general payments places this provider in the 95th percentile of 59 medical oncology providers in Arizona.

See all medical oncology providers in Arizona

Other medical oncology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →